buy cheap phentermine licensed pharmacist

death from meridia

Food and Drug Administration (FDA) has approved Multaq (dronedarone) 400 mg Tablets. The patient population enrolled in the ANDROMEDA and ATHENA studies was significantly different. Multaq should not be given to patients who are or may become pregnant (Category X) or nursing. Multaq should not be coadministered with strong CYP 3A inhibitors or medicinal products that prolong the QT interval. buy cheap phentermine licensed pharmacist The risk mitigation program consists of a Communication Plan for HCPs, a medication guide for patients and post-marketing surveillance. buy cheap phentermine licensed pharmacist Atrial fibrillation is a complex disease that increases the risk of stroke up to five-fold, worsens the prognosis of patients with cardiovascular risk factors, and doubles the risk of mortality. the smashing pumpkins soma

The ATHENA and ANDROMEDA trials provided two sets of data supporting the assessment of the product's benefit risk ratio in two significantly different patient populations.D. About dronedarone (Multaq) Multaq, discovered and developed by sanofi-aventis, is one of the major therapeutic innovations in patients with atrial fibrillation in the last twenty years. buy cheap phentermine licensed pharmacist "It is exciting that Multaq will now be available as a treatment option for patients with paroxysmal or persistent atrial fibrillation or atrial flutter," said Stuart Connolly, M. The efficacy and safety of Multaq 400 mg twice daily was evaluated in five controlled studies, ATHENA, ANDROMEDA, EURIDIS, ADONIS, and DAFNE, involving nearly 6,300 patients including more than 3200 patients who received Multaq. buy cheap phentermine licensed pharmacist LLC also announced the launch of mPACT(TM) - Multaq Partnership for Appropriate Care and Treatment - the Risk Evaluation and Mitigation Strategy (REMS) developed by sanofi-aventis U. "Based on clinical studies, Multaq reduces the risk of cardiovascular hospitalizations in patients with atrial fibrillation / atrial flutter, this outcome could change the way we approach the management of the disease. phentermine online deals

"The FDA approval of Multaq is an important milestone in the management of atrial fibrillation or atrial flutter that demonstrates the commitment of sanofi-aventis to provide patients and physicians with important new medicines in therapeutic areas with significant healthcare needs," said Christopher A. "Sanofi-aventis is proud of its ability to bring innovative therapies to market and contribute to reducing the public health burden of atrial fibrillation. The ATHENA and ANDROMEDA trials provided two sets of data supporting the assessment of the product's benefit risk ratio in two significantly different patient populations. buy cheap phentermine licensed pharmacist S. buy cheap phentermine licensed pharmacist A registration dossier of Multaq is also under regulatory review by the European Medicines Agency (EMEA).